Sunder H. Malkani
Algemeen Directeur bij OcuCure Therapeutics, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Stephen M. Martin | M | 77 |
OcuCure Therapeutics, Inc.
 OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Patricia B. Williams | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Craig M. Greven | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| W. Ben Deibler | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Richard M. Haugen | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
| Paul S. Williams | M | - |
OcuCure Therapeutics, Inc.
OcuCure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuCure Therapeutics, Inc. discovers and develops drugs. It develops technologies to reduce and prevent vision loss caused by eye diseases. The firm provides drugs for treatment of age-related macular degeneration that inhibit new blood vessels from sprouting and causes regression of partially grown blood vessels. The company was founded in 2005 and is headquartered in Roanoke, VA. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 6 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Sunder H. Malkani
- Persoonlijk netwerk
